Pignata, Sandro, Sabrina Chiara Cecere, and Massimo Di Maio. 2016. “Bevacizumab As First-Line Treatment of Ovarian Cancer: Strengths and Weaknesses of Subgroup Analyses:  ”. Cancer Breaking News 4 (1):45-47. https://doi.org/10.19156/cbn.2016.0009.